Both in Pharmaceuticals
BeyondSpring vs Celularity
Over the past year BYSI returned −68.1% and CELU returned −56.9%; their daily moves had a correlation of 0.01.
BYSI −68.1% CELU −56.9%Growth of $1, one year, split-adjusted
| Metric | BYSI | CELU |
|---|---|---|
| Price | $0.6100 | $0.8155 |
| Market cap | $25.1M | $26.5M |
| Today | +18.06% | −3.98% |
| 1 month | −25.0% | −40.9% |
| 6 months | −59.1% | −14.8% |
| Year to date | −62.6% | −26.5% |
| 1 year | −66.7% | −57.7% |
| Revenue growth (YoY) | — | −5.3% |
| Gross margin | — | 56.8% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.4× |
| Net cash | $6.5M | -$37.1M |
| Dividend yield | — | — |
| Volatility (60d) | 158.4% | 223.0% |
| Short % of float | 7.5% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).